186 related articles for article (PubMed ID: 15025256)
1. Role of gut bacteria in the therapy of hepatic encephalopathy with lactulose and antibiotics.
Dasarathy S
Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S50-3. PubMed ID: 15025256
[TBL] [Abstract][Full Text] [Related]
2. Lactulose and combination therapy of hepatic encephalopathy: the role of the intestinal microflora.
Weber FL
Dig Dis; 1996; 14 Suppl 1():53-63. PubMed ID: 8872452
[TBL] [Abstract][Full Text] [Related]
3. Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy.
Bongaerts G; Severijnen R; Timmerman H
Med Hypotheses; 2005; 64(1):64-8. PubMed ID: 15533613
[TBL] [Abstract][Full Text] [Related]
4. Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides.
Morgan MY
Metab Brain Dis; 2016 Dec; 31(6):1361-1364. PubMed ID: 27638474
[TBL] [Abstract][Full Text] [Related]
5. Optimal treatment of hepatic encephalopathy.
Waghray A; Waghray N; Kanna S; Mullen K
Minerva Gastroenterol Dietol; 2014 Mar; 60(1):55-70. PubMed ID: 24632768
[TBL] [Abstract][Full Text] [Related]
6. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Gluud LL; Vilstrup H; Morgan MY
Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
[TBL] [Abstract][Full Text] [Related]
7. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials.
Als-Nielsen B; Gluud LL; Gluud C
BMJ; 2004 May; 328(7447):1046. PubMed ID: 15054035
[TBL] [Abstract][Full Text] [Related]
8. Effects of lactulose on nitrogen metabolism.
Weber FL
Scand J Gastroenterol Suppl; 1997; 222():83-7. PubMed ID: 9145455
[TBL] [Abstract][Full Text] [Related]
9. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy.
Ahire K; Sonawale A
J Assoc Physicians India; 2017 Aug; 65(8):42-46. PubMed ID: 28799305
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy for hepatic encephalopathy.
Phongsamran PV; Kim JW; Cupo Abbott J; Rosenblatt A
Drugs; 2010 Jun; 70(9):1131-48. PubMed ID: 20518580
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo lactose and lactulose effects on colonic fermentation and portal-systemic encephalopathy parameters.
Uribe-Esquivel M; Moran S; Poo JL; Muñoz RM
Scand J Gastroenterol Suppl; 1997; 222():49-52. PubMed ID: 9145447
[TBL] [Abstract][Full Text] [Related]
13. Review article: bacterial flora and pathogenesis in hepatic encephalopathy.
Williams R
Aliment Pharmacol Ther; 2007 Feb; 25 Suppl 1():17-22. PubMed ID: 17295848
[TBL] [Abstract][Full Text] [Related]
14. Probiotics can treat hepatic encephalopathy.
Solga SF
Med Hypotheses; 2003 Aug; 61(2):307-13. PubMed ID: 12888324
[TBL] [Abstract][Full Text] [Related]
15. Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?
Gluud LL; Dam G; Borre M; Les I; Cordoba J; Marchesini G; Aagaard NK; Vilstrup H
Metab Brain Dis; 2013 Jun; 28(2):221-5. PubMed ID: 23275147
[TBL] [Abstract][Full Text] [Related]
16. A Randomized Controlled Trial Comparing the Efficacy of a Combination of Rifaximin and Lactulose with Lactulose only in the Treatment of Overt Hepatic Encephalopathy.
Hasan S; Datta S; Bhattacherjee S; Banik S; Saha S; Bandyopadhyay D
J Assoc Physicians India; 2018 Jan; 66(1):32-6. PubMed ID: 30341842
[TBL] [Abstract][Full Text] [Related]
17. Hepatic encephalopathy: nomenclature, pathogenesis and treatment.
Quero Guillén JC; Carmona Soria I; García Montes JM; Jiménez Sáenz M; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 2003 Feb; 95(2):135-42, 127-34. PubMed ID: 12760720
[TBL] [Abstract][Full Text] [Related]
18. Treatment options for hepatic encephalopathy.
Schiano TD
Pharmacotherapy; 2010 May; 30(5 Pt 2):16S-21S. PubMed ID: 20412036
[TBL] [Abstract][Full Text] [Related]
19. Gut flora and hepatic encephalopathy in patients with cirrhosis.
Riordan SM; Williams R
N Engl J Med; 2010 Mar; 362(12):1140-2. PubMed ID: 20335591
[No Abstract] [Full Text] [Related]
20. Role of antibiotics in the management of hepatic encephalopathy.
Maddrey WC
Rev Gastroenterol Disord; 2005; 5 Suppl 1():S3-9. PubMed ID: 15976746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
